Bhat, K., Saki, M., Vlashi, E., Cheng, F., Duhachek-Muggy, S., Alli, C., . . . Pajonk, F. (2020). The dopamine receptor antagonist trifluoperazine prevents phenotype conversion and improves survival in mouse models of glioblastoma. Proc Natl Acad Sci U S A.
シカゴスタイル引用形Bhat, Kruttika, et al. "The Dopamine Receptor Antagonist Trifluoperazine Prevents Phenotype Conversion and Improves Survival in Mouse Models of Glioblastoma." Proc Natl Acad Sci U S A 2020.
MLA引用形式Bhat, Kruttika, et al. "The Dopamine Receptor Antagonist Trifluoperazine Prevents Phenotype Conversion and Improves Survival in Mouse Models of Glioblastoma." Proc Natl Acad Sci U S A 2020.
警告: この引用は必ずしも正確ではありません.